Blood diseases place a huge burden on individual patients, their families and on wider society. Yet advances in hematology treatment give so much cause for hope. It’s our responsibility to turn that hope into reality. Hear from five bold advocates who inspire us.
Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.
At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.
Novartis Chief Digital Officer Bertrand Bodson says tech professionals don’t need a background in biology to switch industries.
Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.